03.05.2015 Views

IPI - Editorial

IPI - Editorial

IPI - Editorial

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

<strong>IPI</strong><br />

Providing regulatory submissions<br />

in electronic format – US and<br />

EMEA actions<br />

The United States Food and Drug<br />

Administration (FDA) is taking concrete<br />

steps to require the submission of all types<br />

of regulatory communication in electronic<br />

format. Regulatory authorities globally are<br />

all moving to require electronic submission<br />

of regulatory communication. The reasons<br />

are many but the public safety<br />

responsibilities of the regulators require<br />

significantly faster access to content than<br />

can be supported by paper format.<br />

The cost of preparing the content to be<br />

reviewable in electronic format forms the<br />

bulk of the time and human resources<br />

needed to prepare electronic submissions.<br />

Failing to prepare the electronic content in<br />

compliant format can result in the regulatory<br />

authority refusing to conduct the review until<br />

the lack of compliance is corrected – this<br />

could have a profound impact on a<br />

company’s viability if a competitor drug is<br />

approved while the first sponsor is<br />

correcting non-compliant content.<br />

Compliance of electronic documents can<br />

be easily and inexpensively achieved<br />

through the proper use of Microsoft Word to<br />

author documents, combined with the use of<br />

templates with electronic submission<br />

compliance features built into the template<br />

design.<br />

1 HISTORY OF ELECTRONIC<br />

SUBMISSION REQUIREMENTS<br />

1.1 US FDA<br />

• FDA Centers for Drug Evaluation and<br />

Research (CDER) and Biologic Evaluation<br />

and Research (CBER) have required<br />

submission of electronic case report<br />

tabulations (CRTs) and case report forms<br />

(CRFs) in electronic format for new drug<br />

and new biologic license applications<br />

(NDAs and BLAs) since 1999 , .<br />

• FDA CDER has required package inserts<br />

to be submitted in electronic Structured<br />

Product Labeling (SPL) format since<br />

October 1, 2005 .<br />

• FDA CDER has required electronic<br />

submissions to be presented in the<br />

electronic Common Technical Document<br />

(eCTD) format since January 1, 2008 .<br />

• FDA is requiring the content of the Drug<br />

Establishment and Drug Registration<br />

forms to be submitted in electronic format<br />

beginning June 1, 2009 .<br />

• FDA has published the proposed rule that<br />

retired previous electronic submission<br />

formats, and set the stage to require all<br />

submissions be in electronic format using<br />

the eCTD organisation structure and<br />

electronic navigation aids .<br />

1.2 EMEA<br />

The electronic submission juggernaut is<br />

not limited to the US market:<br />

• The European Medicines Evaluation<br />

Agency has announced a timeline which<br />

requires all agencies participating in the<br />

centralised procedure for marketing<br />

authorisation applications (MAA) to begin<br />

submitting in electronic format on January<br />

1, 2009 , and in the eCTD format on<br />

January 10, 2010.<br />

Finally, there is an international effort<br />

underway with involvement by regulatory<br />

authorities and industry to define the next<br />

generation of bi-directional communication<br />

of regulatory submission content in a<br />

messaging format called Regulated Product<br />

Submission that is intended to address<br />

electronic submission requirements for all<br />

products regulated by FDA – drugs,<br />

biologics, devices, veterinary medicine, food<br />

additives, and cosmetics.<br />

2 TECHNICAL REQUIREMENTS<br />

Since 1999, the fundamental building block<br />

of electronic submissions has been the<br />

Adobe Acrobat Portable Document Format<br />

(PDF). However, this is not ordinary run-ofthe-mill<br />

PDFs created by scanning or<br />

printing to Adobe PDF. All regulatory<br />

authorities who accept electronic<br />

submissions have very strict requirements<br />

for the format and electronic navigation aids<br />

within PDF files, Regulatory authorities<br />

globally have refused to review electronic<br />

submissions whose PDF files lacked<br />

required navigation aids.<br />

All of these requirements can be met by<br />

implementing MS Word templates and<br />

configuring PDF conversion to support<br />

these requirements. PDF conversion can be<br />

done via PDFMaker, a plug-in to the<br />

Microsoft Office suite that is automatically<br />

implemented when the Microsoft Office<br />

applications are installed first, and Adobe<br />

Acrobat Standard or Professional are<br />

installed second. These properties can also<br />

be assured by correct configuration of<br />

Acrobat Distiller. Further, companies with<br />

MasterControl electronic document<br />

management systems (EDMS) configured<br />

for life sciences applications frequently have<br />

a PDF rendition server or generator in the<br />

EDMS suite that can be configured to<br />

support the requirements that are identified<br />

below.<br />

FDA has published guidance that<br />

describes the requirements for PDF files for<br />

eCTD submissions, Portable Document<br />

Format Specifications, version 2.0, dated<br />

2008-0604,www.fda.gov/cder/<br />

regulatory/ersr/ PDF_specification_v2.pdf.<br />

Other regulatory authorities have published<br />

requirements that are virtually identical to<br />

the guidance supplied by FDA.<br />

2.1 Fundamental PDF Requirements<br />

One of the strongest directives from the<br />

regulatory authorities’ requirements is that<br />

PDF files conform to predefined page sizes,<br />

have adequate margins on all sides and<br />

have adequate font sizes for legibility.<br />

These translate into the following<br />

specifications:<br />

• US letter page size for the FDA<br />

• A4 page size for rest of the world<br />

• Margins of at least one inch on all four<br />

borders, with larger margins on the<br />

binding edge in the event that paper<br />

volumes will be required<br />

• Times New Roman or Arial font, with the<br />

body text in 12 point and tables no smaller<br />

than 10 point<br />

34 <strong>IPI</strong> www.ipimedia.com

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!